Changeflow GovPing Healthcare & Life Sciences Hexacath Catheter Patent, Thermodilution Blood ...
Routine Rule Added Final

Hexacath Catheter Patent, Thermodilution Blood Flow Determination

Favicon for changeflow.com EPO Patent Bulletin - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4164520A1 for Hexacath's dual-action catheter system combining thermodilution blood flow measurement with body obstruction destruction capability. Named inventors are Gilles Ascher, Bernard De Bruyne, and Nico Pijls. The patent covers 32 designated European member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Diagnosis & Surgery (A61B) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 66 changes logged to date.

What changed

The European Patent Office granted patent EP4164520A1 to Hexacath for a catheter system integrating both thermodilution blood flow measurement and body obstruction destruction functions within a single device. The filing designates 32 European Patent Convention member states covering major medical device markets.

Medical device manufacturers and healthcare technology companies developing catheter-based measurement or treatment systems should review this patent for potential freedom-to-operate implications in European markets. Competitors in the cardiac and vascular intervention space should monitor Hexacath's expanding IP portfolio covering dual-action catheter technologies.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

CATHETER SYSTEMS FOR HAVING BOTH A THERMODILUTION ACTION AND A BODY OBSTRUCTION DESTRUCTION ACTION, AND METHODS FOR DETERMINING BLOOD FLOW RATES AND FOR PERFORMING BODY OBSTRUCTION DESTRUCTION

Publication EP4164520A1 Kind: A1 Apr 15, 2026

Applicants

Hexacath

Inventors

ASCHER, Gilles, DE BRUYNE, Bernard, PIJLS, Nico

IPC Classifications

A61B 17/3203 20060101AFI20211217BHEP A61B 17/22 20060101ALI20211217BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Parties

Get daily alerts for EPO Patent Bulletin - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent granting Medical device IP
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!